132 related articles for article (PubMed ID: 6408180)
21. Visceral leishmanicidal activity of hexadecylphosphocholine (miltefosine) in mice deficient in T cells and activated macrophage microbicidal mechanisms.
Murray HW; Delph-Etienne S
J Infect Dis; 2000 Feb; 181(2):795-9. PubMed ID: 10669380
[TBL] [Abstract][Full Text] [Related]
22. Macrophages as effector cells of protective immunity in murine schistosomiasis. V. Variation in macrophage schistosomulacidal and tumoricidal activities among mouse strains and correlation with resistance to reinfection.
James SL; Skamene E; Meltzer MS
J Immunol; 1983 Aug; 131(2):948-53. PubMed ID: 6863937
[TBL] [Abstract][Full Text] [Related]
23. Suppression of macrophage oxidative metabolism by products of malignant and nonmalignant cells.
Szuro-Sudol A; Nathan CF
J Exp Med; 1982 Oct; 156(4):945-61. PubMed ID: 7153714
[TBL] [Abstract][Full Text] [Related]
24. [Effects of cytokine-activated macrophages on intracellular leishmania].
Xue C; Kaye P
Zhonghua Yi Xue Za Zhi; 1995 Jun; 75(6):338-40, 382. PubMed ID: 7553143
[TBL] [Abstract][Full Text] [Related]
25. The oxidative metabolism of thioglycollate-elicited mouse peritoneal macrophages: the relationship between oxygen, superoxide and hydrogen peroxide and the effect of monolayer formation.
Cohen MS; Ryan JL; Root RK
J Immunol; 1981 Sep; 127(3):1007-11. PubMed ID: 6267128
[TBL] [Abstract][Full Text] [Related]
26. Susceptibility of Eimeria bovis and Toxoplasma gondii to oxygen intermediates and a new mathematical model for parasite killing.
Hughes HP; Boik RJ; Gerhardt SA; Speer CA
J Parasitol; 1989 Aug; 75(4):489-97. PubMed ID: 2760759
[TBL] [Abstract][Full Text] [Related]
27. Resistance to macrophage-mediated killing as a factor influencing the pathogenesis of chronic cutaneous leishmaniasis.
Scott P; Sacks D; Sher A
J Immunol; 1983 Aug; 131(2):966-71. PubMed ID: 6863939
[TBL] [Abstract][Full Text] [Related]
28. Macrophages and resistance of tumors 6. The effects of supernatants from cultures of normal and tumor cells on phagocytosis.
Nelson M; Nelson DS
J Reticuloendothel Soc; 1982 May; 31(5):433-50. PubMed ID: 7120229
[TBL] [Abstract][Full Text] [Related]
29. Cell-mediated immune response in experimental visceral leishmaniasis. I. Correlation between resistance to Leishmania donovani and lymphokine-generating capacity.
Murray HW; Masur H; Keithly JS
J Immunol; 1982 Jul; 129(1):344-50. PubMed ID: 7086136
[No Abstract] [Full Text] [Related]
30. Toxoplasmacidal activity of Obioactin derived from hydrolyzed Toxoplasma immune bovine serum in heterologous cell cultures.
Suzuki N; Izumo A; Sakurai H; Saito A; Miura H; Osaki H
Zentralbl Bakteriol Mikrobiol Hyg A; 1984 Mar; 256(3):356-66. PubMed ID: 6328796
[TBL] [Abstract][Full Text] [Related]
31. Susceptibility of Leishmania to oxygen intermediates and killing by normal macrophages.
Murray HW
J Exp Med; 1981 May; 153(5):1302-15. PubMed ID: 7252418
[TBL] [Abstract][Full Text] [Related]
32. Antitumor activity and hydrogen peroxide release by macrophages elicited by trehalose diesters.
Lepoivre M; Tenu JP; Lemaire G; Petit JF
J Immunol; 1982 Aug; 129(2):860-6. PubMed ID: 6806386
[TBL] [Abstract][Full Text] [Related]
33. [Influences of inflammatory macrophages on the proliferation of mouse tumor cells in vitro].
Sun DM; Hu XZ; Shi W; Zhang YH
Zhonghua Zhong Liu Za Zhi; 1986 Jul; 8(4):247-9. PubMed ID: 3093180
[TBL] [Abstract][Full Text] [Related]
34. Activation of tumor-cytostatic macrophages with the antitumor agent 9,10-anthracenedicarboxaldehyde bis[(4,5-dihydro-1H-imidazole-2-yl)hydrazone] dihydrochloride (bisantrene).
Wang BS; Lumanglas AL; Ruszala-Mallon VM; Durr FE
Cancer Res; 1984 Jun; 44(6):2363-7. PubMed ID: 6426780
[TBL] [Abstract][Full Text] [Related]
35. Control of Leishmania major infection in mice lacking TNF receptors.
Nashleanas M; Kanaly S; Scott P
J Immunol; 1998 Jun; 160(11):5506-13. PubMed ID: 9605154
[TBL] [Abstract][Full Text] [Related]
36. Complete protection against experimental visceral leishmaniasis with complete soluble antigen from attenuated Leishmania donovani promastigotes involves Th1-immunity and down-regulation of IL-10.
Bhaumik SK; Naskar K; De T
Eur J Immunol; 2009 Aug; 39(8):2146-60. PubMed ID: 19593771
[TBL] [Abstract][Full Text] [Related]
37. Secretion of oxygen intermediates: role in effector functions of activated macrophages.
Nathan CF
Fed Proc; 1982 Apr; 41(6):2206-11. PubMed ID: 6281078
[TBL] [Abstract][Full Text] [Related]
38. Alteration of Leishmania donovani infection levels by selective impairment of macrophage signal transduction.
Moore KJ; Labrecque S; Matlashewski G
J Immunol; 1993 May; 150(10):4457-65. PubMed ID: 8482844
[TBL] [Abstract][Full Text] [Related]
39. Cyclosporin A-mediated killing of Leishmania major by macrophages is independent of reactive nitrogen and endogenous TNF-alpha and is not inhibited by IL-10 and 13.
Meissner U; Jüttner S; Röllinghoff M; Gessner A
Parasitol Res; 2003 Feb; 89(3):221-7. PubMed ID: 12541065
[TBL] [Abstract][Full Text] [Related]
40. Unique differences in infectivity and seroreactivity of Toxoplasma harvested from mice infected for different lengths of time.
McCabe RE; Catterall JR; Remington JS
J Parasitol; 1987 Dec; 73(6):1152-7. PubMed ID: 3437353
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
